Visit the Caliper Life Sciences web site

Latest news on Laboratorytalk categorised by supplier

Lipomics Technologies

Address:
3410 Industrial Boulevard
West Sacramento
95691
USA
Telephone: (USA) +1 916 371 7974

http://www.lipomics.com

Our RSS feed for news from Lipomics Technologies

Request to receive our free email newsletter each week

 

Listing of all 21 news releases from Lipomics Technologies:

Liver disease diagnostic development programme

Lipomics is developing blood-based diagnostics for the early detection of non-alcoholic fatty liver disease (NAFLD), and the ability to distinguish between it and non-alcoholic steatohepatitis (Nash)

News from Lipomics Technologies (18 March 2008)

Lipomics collaborates with Joslin Diabetes Center

Lipomics Technologies, which specialises in clinical diagnostic development, is engaged in a research collaboration with Joslin Diabetes Center's insulin resistance research

News from Lipomics Technologies ( 6 February 2008)

Research deal covers pharmacometabolic markers

Lipomics Technologies has entered into a two-year collaborative research agreement with Duke University in several key clinical areas to identify pharmacometabolomic markers

News from Lipomics Technologies (23 May 2007)

Diagnostic panels to be based on clinical trials

Lipomics Technologies enters agreement with Isis Pharmaceuticals to provide lipid-focused support of preclinical and clinical trial testing for various compounds to treat metabolic disease

News from Lipomics Technologies (16 February 2007)

Developing better diagnostic biomarker assays

Agilent and Lipomics Technologies will collaborate to develop research and diagnostic assays combining Agilent analytical platforms with Lipomics's expertise in biomarker discovery and validation

News from Lipomics Technologies (14 February 2007)

New director of finance and operations

Lipomics Technologies has announced that Scott Van Buskirk has joined the company in the newly created position of director of finance and operations

News from Lipomics Technologies (26 September 2006)

Grant for lipid analysis fitness assessment study

Lipomics Technologies has been selected to receive a Phase II Small Business Technology Transfer Grant from the US Department of Defense to improve optimum fitness and performance of combat personnel

News from Lipomics Technologies (15 September 2006)

Lipomics Technologies hires chief medical officer

Lipomics Technologies, specialising in the comprehensive and quantitative profiling of lipid metabolites, announced that Meeta Patnaik has joined in the newly created position of chief medical officer

News from Lipomics Technologies ( 8 September 2006)

Comprehensive acylcarnitine profiling assay

Assay profiling targeted towards companies and organisations involved in metabolism research and the development of new drugs

News from Lipomics Technologies (22 March 2006)

Comprehensive eicosanoid profiling becomes reality

For the first time, says the company, a complete understanding of underlying eicosanoid metabolism can be obtained from a single platform

News from Lipomics Technologies (26 October 2005)

Two key additions to scientific advisory board

Professors Hotamisligil from Harvard's School of Public Health and Spector from the University of Iowa to advise Lipomics on research into the causes of obesity, diabetes and heart disease

News from Lipomics Technologies (26 October 2005)

Guest speaker at genomics and proteomics meeting

Presentation addressed metabolomics, focusing on small molecule metabolites that are proximal effectors of health and disease and hold promise in many aspects of drug development and personal medicine

News from Lipomics Technologies (25 October 2005)

New VP of commercial development

Peter Matlock looks forward to applying metabolic profiling to improve the pharmaceutical discovery and development process, develop better nutritional products and enable individualised healthcare

News from Lipomics Technologies (26 April 2005)

New CTO and bioinformatics VP

Don Morris, one of the founding scientists at Affymetrix and the holder of numerous patents, becomes chief technology officer and vice president of bioinformatics at Lipomics

News from Lipomics Technologies (27 January 2005)

Lipomic profiling to tackle autism

Results from this study may offer clues about the causes of autism and may lead to better therapeutics for this and other neurodevelopmental disorders

News from Lipomics Technologies (20 December 2004)

Using lipid analysis to assess fitness

Study results to help predict fitness and endurance of combat personnel by analysing and profiling structural changes in plasma metabolites

News from Lipomics Technologies (28 October 2004)

Larger facility for expanded lipomic profiling

Lipomics Technologies, a privately held company that specialises in lipid metabolite analysis and interpretation, has moved its operations to a new, larger facility

News from Lipomics Technologies (15 September 2004)

Appointment of visiting scientist

Rosemary Walzem's research involves the structure of lipoproteins and mechanisms and regulatory processes that control the assembly of triglyceride-rich lipoproteins in tissues

News from Lipomics Technologies ( 7 October 2003)

Metabolic pathway maps and flux equations

Metabolic pathway maps assemble the results of lipid metabolite measurements, with flux equations, to generate an informative graphical representation of a lipid metabolism

News from Lipomics Technologies ( 9 September 2003)

Lipid research agreement

Lipomics Technologies announces agreement with GlaxoSmithKline for access to lipid metabolite research and interpretation

News from Lipomics Technologies ( 5 August 2003)

New CEO and chief scientific officer

 

Send us a blank email now to get our free regular email newsletter from the Editor
Laboratorytalk news by product category
Laboratorytalk news by date
Laboratorytalk news by manufacturer
Laboratorytalk Home Page


 

Register for the FREE Laboratorytalk email newsletter now! News about Contract research and more every issue. Click here for details.